Drug Allergy and Hypersensitivity

Pascal Demoly, MD, PhD
Hôpital Arnaud de Villeneuve, University Hospital of Montpellier
IDESP, University of Montpellier – INSERM
Montpellier, France

Pascal Demoly


Dear Colleagues,

Drug hypersensitivity/allergy reactions have a significant impact on clinical practice, socio-economy, drug development, and public health and allergists are sharing more and more their experience and research. The World Allergy Organization Journal is supporting the move by dedicating efforts to publish new knowledge in the field.

There are still many unresolved questions in drug hypersensitivity/allergy reactions, including basic immunological understanding and management.1,2 New teams are involved expending previous knowledge, new collaborative projects are standardizing procedures, all in all generating valuable data. Amongst them are some immunological discoveries, the use of bigger databases, including electronic health records, analyzed with modern mathematic tools and the real life testing of predictive algorithms, clinical decision support systems, paving the ground for fine-tuning the drug allergy pathways, drug allergy labelling, and delabeling. 

1- Demoly P, Castells M. Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium. World Allergy Organ J 2018; 11(1): 42.

2- Demoly P, Ramsey A. Drug allergy management on the move. J Allergy Clin Immunol Pract. 2021; 9(8): 3021-3022. 

We invite our colleagues to send their original works, reviews, and meta-analysis to our section.

Pascal Demoly


About Pascal Demoly

Pascal Demoly, MD, PhD, is a respiratory physician and allergist, Professor of Pulmonology and Head of Department at the University Hospital of Montpellier. He is the director of the INSERM research unit IDESP focusing on epidemiology and public health of chronic non-communicable diseases, massive health and environmental data, and modern mathematics.

Prof. Demoly is president of the French Allergy Society (2010-2012 and again 2022-2024); he is chairing (2019-2021) the French National Council for Allergology. In addition, he is a member of several national and international editorial boards of allergy journals and a full member of the French National Academy of Medicine.

In the last years, his research interest has focused mainly on allergy (rhinitis, asthma diagnosis and treatment, allergen immunotherapy, anaphylaxis, and drug allergy) where he has extensive experience lecturing.

Prof. Demoly has published more than 900 articles including more than 600 in international peer-reviewed journals (H factor over 100 and citations over 58000, 2018 and 2021 Clarivate Analytics Highly Cited Researcher, category immunology) and is chair of the WHO Collaborating Center on Scientific Classification Support at the University Hospital of Montpellier.